Correlation Between Dermata Therapeutics and Legend Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Legend Biotech Corp, you can compare the effects of market volatilities on Dermata Therapeutics and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Legend Biotech.

Diversification Opportunities for Dermata Therapeutics and Legend Biotech

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Dermata and Legend is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Legend Biotech go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Legend Biotech

Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Legend Biotech. In addition to that, Dermata Therapeutics is 3.17 times more volatile than Legend Biotech Corp. It trades about -0.08 of its total potential returns per unit of risk. Legend Biotech Corp is currently generating about -0.07 per unit of volatility. If you would invest  5,524  in Legend Biotech Corp on July 7, 2024 and sell it today you would lose (617.00) from holding Legend Biotech Corp or give up 11.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dermata Therapeutics  vs.  Legend Biotech Corp

 Performance 
       Timeline  
Dermata Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dermata Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Dermata Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Legend Biotech Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Legend Biotech Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Legend Biotech may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Dermata Therapeutics and Legend Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dermata Therapeutics and Legend Biotech

The main advantage of trading using opposite Dermata Therapeutics and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.
The idea behind Dermata Therapeutics and Legend Biotech Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets